Celltrion's Yuflyma to Accelerate Prescription Growth with Costco Sale

COMPANY / Reporter Kim Jisun / 2024-08-14 03:32:54

Seo Jung-jin, honorary chairman of Celltrion (photo= Celltrion)

 

[Alpha Biz= Reporter Kim Jisun] Celltrion's Yuflyma to Accelerate Prescription Growth with Costco Sale

Celltrion announced on August 13 that its self-immune disorder treatment, Yuflyma (ingredient: adalimumab), is now available for purchase at Costco, a major U.S. retailer. The drug was registered with the Costco Member Prescription Program (CMPP) as of August 1 (local time).

The CMPP allows Costco members to buy medications at discounted prices from in-store or affiliated pharmacies. Starting this month, uninsured Costco members and their dependents can purchase Low WAC Yuflyma at a reduced price from Costco stores and partner pharmacies across the U.S.

 

 

Alphabiz Reporter Kim Jisun(stockmk2020@alphabiz.co.kr)

어플

주요기사

Sampyo Group Chairman Indicted Over Alleged Unfair Support to Son’s Company
Kumho Tire Posts ₩1.11 Trillion Revenue and ₩108.5 Billion Operating Profit in Q3
KT CEO Kim Young-sub to Step Down; Board Launches Open Recruitment for New Leader
NH Investment & Securities Bans Executives from Trading Domestic Stocks Amid Internal Control Review
Korea Privacy Dispute Panel Orders SK Telecom to Pay ₩300,000 Per Subscriber Over Data Leak
뉴스댓글 >

SNS